Goes Hostile for Aurora Cannabis in US$4.00 A Share Offer

Curaleaf Goes Hostile for Aurora Cannabis in US$4.00 A Share Offer

Curaleaf Holdings (TSX: CURA) is going over the heads of Aurora Cannabis’ (TSX: ACB) board.

The company said it intends to launch a formal takeover bid for Aurora, offering US$4.00 per share in cash and stock to fold the Canadian medical producer into what Curaleaf bills as the cannabis industry’s first global platform.

Each Aurora share would be exchanged for 0.3463 Curaleaf subordinate voting shares plus US$0.75 in cash. That works out to a 45% premium to Aurora’s 30-day volume-weighted average price of US$2.75, or 110% once the company’s balance sheet cash is stripped out. Depending on where Curaleaf’s own stock trades, the consideration could stretch as high as US$5.00 per share under a cap tied to a 20-day VWAP, lifting the premium to 82%, or 197% excluding cash.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

The bid would remain open for 105 days once commenced, with the option to extend. There are no due diligence or financing conditions attached. Offer documents are to be filed with Canadian securities regulators and the U.S. Securities and Exchange Commission.

The rationale is part geography, part arithmetic. Together, the two companies would operate across 17 countries with roughly US$1.5 billion in trailing twelve-month revenue and close to US$350 million in adjusted EBITDA, at a pro forma market capitalization near US$3.0 billion. Aurora brings more than 50 tons of annual EU-GMP cultivation capacity; Curaleaf brings the processing, distribution and retail reach to move it. Management pegs cost synergies at a minimum of US$40 million annually, with revenue gains on top of that.

Then there is the American angle. Aurora shareholders would pick up exposure to a US$32 billion U.S. cannabis market that Curaleaf argues is finally seeing regulatory tailwinds.

“We believe this combination represents a win-win for Curaleaf and Aurora shareholders,” said Boris Jordan, chairman and chief executive officer. “We approached Aurora privately and constructively on multiple occasion… We were very disappointed that the Board refused to meaningfully engage.”

Those approaches began with a formal letter of intent on June 23, followed by a second letter on July 7 after Aurora’s leadership declined to enter discussions.

“We will now take our proposal directly to Aurora shareholders because the premium is significant, the strategic rationale is compelling, and further delay is unjustified,” Jordan said, adding that Curaleaf “remains ready to engage constructively with Aurora’s Board to advance this value-maximizing transaction.”

Curaleaf has reserved the right to abandon the bid if Aurora adopts defensive tactics, such as a shareholder rights plan, a major asset sale, a sizable acquisition, a significant share issuance, or agrees to a competing transaction.

Curaleaf last traded at $1308 on the TSX.

Information for this briefing was found via the sources and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
Video Articles

This Gold Giant Got Crushed… Now It’s the Cheapest Major | Kinross Gold’s Q3 Earnings

Why I’m Still Bullish on Gold Below $3,900 | Wes Hanson – Thunder Gold

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Curaleaf: Canccord Slashes Price Target, Anticipates Headwinds For 2022

Earlier this month, Curaleaf Holdings, Inc. (CSE: CURA reported its fourth quarter and full year...

Monday, March 14, 2022, 09:27:00 AM

Aurora Cannabis To Conduct 12 to 1 Reverse Split, Launch New ATM Program

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has given in. It has finally announced that it...

Monday, April 13, 2020, 08:04:32 AM

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Aurora Cannabis Permitted To Expand German Operations

Following in the footsteps of Tilray Brands (TSX: TLRY), Aurora Cannabis (TSX: ACB) has now...

Thursday, July 25, 2024, 10:32:37 AM

Curaleaf To Acquire Arizona Dispensary For US$13.0 Million, Relocate It 161 Miles Away

Curaleaf Holdings (CSE: CURA) is expanding its presence in Arizona yet again. The company this...

Thursday, December 23, 2021, 09:15:01 AM